Basel research set to improve child vaccines

The Basel-based Swiss Tropical and Public Health Institute has uncovered new insights into the immune systems of children. This new understanding could help to improve the efficacy of vaccines. Children are set to benefit from the expertise of Basel research to an even greater extent in the future.

Swiss TPH
New findings benefit the development of vaccines for children in low and middle-income countries. Image Credit: Christian Heuss, Swiss TPH

Together with the Babraham Institute and the Barcelona Institute for Global Health (ISGlobal), among other organizations, the Swiss Tropical and Public Health Institute (Swiss TPH) has been investigating the immune systems of children. This research revealed that the composition of the immune system and the children’s reactions to vaccines can be influenced by a myriad of factors. These also include non-genetic factors such as age, the country in which they grow up and anemia status, as detailed in a press release issued by the Swiss TPH.  

According to the Swiss TPH, vaccines are often less effective in children that live in low and middle-income countries. It should also be noted that children in these countries are more dependent on vaccination protection due to the fact that infectious diseases occur more frequently than in countries with high incomes. The researchers’ new findings could now help to develop more effective vaccines for children in various regions around the world.

Across the world, the Swiss TPH is a renowned institute in the field of global health. It is based in Basel and works in close cooperation with the University of Basel. The Basel region is increasingly evolving into a pediatrics hub. In this context, the Botnar Research Center for Child Health (BRCCH) has recently started research activities in the area. It presented its first four research projects during a Spotlight Day on January 30. Moreover, the local business promotion organization is also supporting startups active in the area of digital health that seek to promote the health of children and young people by way of its DayOne Accelerator.

Handbook for Investors

Our Handbook for Investors provides valuable information about technologies and production costs, taxes and financing, as well as the legal system and infrastructure in Switzerland. Browse through the complete handbook online or download the chapters most relevant to you.

Recommend us
How should we contact you?

Premium Partner

Strategic partners

Institutional partner

Official program